盛禾生物控股有限公司（02898）于2026年1月2日公布2025年12月的股份变动月报表。报告显示，截至2025年12月31日，公司注册股本维持在200,000,000股，每股面值USD 0.0005，合计注册股本USD 100,000，未见任何增减。
公司已发行股份方面，普通股由上月底的156,666,800股维持至本月底156,666,800股，当月无新增发行、回购或注销活动，也无库存股变动。同时，公告显示，本月无任何股份期权、可换股票据或其他相关激励计划的变动。
整体而言，截至2025年12月31日，盛禾生物控股有限公司股本总数保持不变，公司声明遵守了香港联交所《上市规则》及相关法律规定。上述月报由公司主席兼执行董事张峰签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.